Newsmeme!
Discover News you didn't know existed
Stem Cell Sciences plc, (SCS) a company focused on the commercialisation of stem cells and stem cell technologies, has signed a master service agreement of up to five years with Pfizer Limited, the UK operating unit of the global research-based pharmaceutical company Pfizer, Inc. Under the terms of the agreement, SCS will provide research services, cell lines, media and reagents to support ...
Transplant officials seek to increase pool of younger donors: ‘We should be talking about organ donation early; there shouldn't be a big mystery about it'
These pure insulin-producing cells, which according to electron microscopy studies, have the same sub-cellular structures as the insulin-producing cells naturally found in the pancreas, were highly effective in treating diabetes in the mouse model.
Canadian Blood Services is launching a new initiative that will make it easier for donors who are Deaf, deafened or hard of hearing to give blood. Until now, these potential donors were only able to donate if they could communicate directly with the screening nurse in written English or French.
One year after researchers discovered a major alternative to embryonic stem cells, the remarkable bit of modern-day alchemy is still shaking the scientific world.
SINGAPORE: Pure insulin—producing cells, similar to those found in the human pancreas, have been developed in the lab by a team of Singapore researchers working with mouse embryonic stem cells.
The promise of stem cell therapies is growing ever closer to becoming realized in the medical setting. In a recent study, a team from the Hopkins School of Medicine used imaging technology to watch adult cardiac stem cells as they colonized the injured heart of a rat.
Researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells. The cells, which have the same sub-cellular structures as the insulin-producing cells naturally found in the pancreas, were highly effective in treating diabetes in the mouse model.
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience.
(PhysOrg.com) -- Biomaterial scientists in Manchester believe they have found a new way of isolating the ‘ingredients` needed for potential stem cell treatments for nerve damage and heart disease.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |